World hepatitis day in Burkina Faso, 2017: seroprevalence and vaccination against hepatitis B virus to achieve the 2030 elimination goal

BACKGROUND: Burkina Faso is a high endemicity country for HBV infection. However, there are few data on vaccine coverage against HBV. The aim of this study was to contribute to the improvement of HBV vaccine coverage in Ouagadougou through HBV screening. METHODS: Awareness campaigns and voluntary he...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Virol J
Главные авторы: Diarra, Birama, Yonli, Albert Theophane, Ouattara, Abdoul Karim, Zohoncon, Theodora Mahoukèdè, Traore, Lassina, Nadembega, Christelle, Obiri-Yeboah, Dorcas, Yara, Justine, Pietra, Virginio, Ouedraogo, Paul, Bougouma, Alain, Sanogo, Rokia, Simpore, Jacques
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2018
Предметы:
Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6080359/
https://ncbi.nlm.nih.gov/pubmed/30081915
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12985-018-1032-5
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы